Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGS-742 in SSADH Deficiency
NCT02019667Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Mar 2014
- Primary completion
- Jan 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SGS-742 in succinic semialdehyde dehydrogenase deficiency, sponsored by National Institute of Neurological Disorders and Stroke. Started Mar 2014; status: completed.
02
Drugs
SGS-742
03
Conditions
succinic semialdehyde dehydrogenase deficiency
Beyond the preview
Go deeper on NCT02019667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019667.